| Literature DB >> 33602058 |
S Coughlan1, A Das1,2, E O'Herlihy1, F Shanahan1,3, P W O'Toole1,2,3, I B Jeffery1.
Abstract
Irritable Bowel Syndrome (IBS), the most common gastrointestinal disorder, is diagnosed solely on symptoms. Potentially diagnostic alterations in the bacterial component of the gut microbiome (the bacteriome) are associated with IBS, but despite the known role of the virome (particularly bacteriophages), in shaping the gut bacteriome, few studies have investigated the virome in IBS. We performed metagenomic sequencing of fecal Virus-Like Particles (VLPs) from 55 patients with IBS and 51 control individuals. We detected significantly lower alpha diversity of viral clusters comprising both known and novel viruses (viral 'dark matter') in IBS and a significant difference in beta diversity compared to controls, but not between IBS symptom subtypes. The three most abundant bacteriophage clusters belonged to the Siphoviridae, Myoviridae, and Podoviridae families (Order Caudovirales). A core virome (defined as a cluster present in at least 50% of samples) of 5 and 12 viral clusters was identified in IBS and control subjects, respectively. We also identified a subset of viral clusters that showed differential abundance between IBS and controls. The virome did not co-vary significantly with the bacteriome, with IBS clinical subtype, or with Bile Acid Malabsorption status. However, differences in the virome could be related back to the bacteriome as analysis of CRISPR spacers indicated that the virome alterations were at least partially related to the alterations in the bacteriome. We found no evidence for a shift from lytic to lysogenic replication of core viral clusters, a phenomenon reported for the gut virome of patients with Inflammatory Bowel Disease. Collectively, our data show alterations in the virome of patients with IBS, regardless of clinical subtype, which may facilitate development of new microbiome-based therapeutics.Entities:
Keywords: Bacteriophage; bile acid malabsorption; gut microbiota; irritable bowel syndrome; virome
Mesh:
Year: 2021 PMID: 33602058 PMCID: PMC7899630 DOI: 10.1080/19490976.2021.1887719
Source DB: PubMed Journal: Gut Microbes ISSN: 1949-0976
Clinical features of control and IBS subjects
| Control (n = 51) | IBS (n = 55) | |
|---|---|---|
| Age range, years (mean) | 20–64 (45) | 18–66 (40) |
| Sex (male/female) | 12/39 | 14/41 |
| BMI Class, n (%) | ||
| Normal | 21 (41) | 24 (44) |
| Obese Class I | 10 (20) | 7 (13) |
| Obese Class II | 3 (6) | 4 (7) |
| Obese Class III | 1 (2) | 3 (5) |
| Overweight | 15 (29) | 16 (29) |
| Underweight | 1 (2) | 1 (2) |
| HADS: Anxiety, n (%) | ||
| Normal (0–10) | 46 (90) | 43 (78) |
| Abnormal (11–21) | 5 (10) | 12 (22) |
| HADS: Depression, n (%) | ||
| Normal (0–10) | 51 (100) | 48 (87) |
| Abnormal (11–21) | 0 (0) | 7 (13) |
| Bristol Stool Score, n (%) | ||
| Normal | 43 (84) | 15 (27) |
| Constipated | 7 (14) | 15 (27) |
| Diarrhea | 1 (2) | 25 (46) |
| IBS subtype, n (%) | ||
| IBS-C | 21 (38) | |
| IBS-D | N/A | 17 (31) |
| IBS-M | 17 (31) | |
| SeHCAT assayed, n (%) | 9 (18) | 31 (56) |
| Dietary group (FFQ), n (%) | ||
| Omnivore | 49 (96) | 52 (94) |
| Vegetarian | 1 (2) | 2 (4) |
| Pescatarian | 1 (2) | 0 (0) |
| Gluten-free | 0 (0) | 1 (2) |
| Drinks alcohol, n (%) | ||
| Current | 46 (90) | 39 (71) |
| Previous | 0 (0) | 0 (0) |
| Never | 5 (10) | 16 (29) |
| Smoker, n (%) | ||
| Current | 7* (14) | 7* (13) |
| Previous | 8 (16) | 14 (25) |
| Never | 36 (70) | 34 (62) |
* 1 subject in each group smoked e-cigarettes; N/A not applicable
Figure 2.Difference in viral diversity between IBS and Controls. A) Boxplots of richness (observed) and alpha diversity (Shannon) estimates for IBS and control samples (Control: n = 51; IBS: n = 55 (IBS-C: n = 21; IBS-D: n = 17; IBS-M: n = 17) computed from viral cluster counts, showing significant differences (Wilcoxon rank-sum test p < .05) between IBS and controls. B). Barplots showing the total abundance of each viral family in control and IBS populations by prevalence in each population)
Figure 1.Confidence in taxonomic classifications, as measured by percentage query coverage and percent identity for protein sequences, predicted from the pooled contigs from IBS (n = 55) and control samples (n = 51), (n = 51,703 contigs). Each protein sequence was taxonomically classified using its top Diamond hit to the viral component of the UniProtKB TrEMBL database. Where the percentage of the query length covered was >100 due to gaps in the alignment, the coverage value was set to a value of 100. Family abundance was calculated by summing the abundance of all contigs assigned to that family and percentage family abundance calculated as the abundance of a family divided by the abundance of all families. Dashed lines indicate 75% identity and query coverage
Figure 3.Difference in viral clusters between IBS and Controls. A) PCoA generated using the Bray-Curtis dissimilarity of viral cluster abundances (log-of abundance with pseudocount) between IBS and control samples showing a significant split between IBS and Control subjects (R2 = 0.0145, PMANOVA p-value = 0.001). The significant split was associated with the second eigenvector only (t.test p-value = 0.0004). PCoA1 is on the vertical axis, while PCoA2 is on the horizontal axis. B) Visualization of viral clusters using Canonical Correlation analysis with the Spearman methodology. Clusters significantly associated with the second eigenvector are highlighted as dark gray (n = 116). Of the 116 significant clusters, 114 are negatively associated with the second eigenvector showing a reduction in abundance and/or prevalence of these viral clusters across the PCoA2 axis which is associated with the IBS vs Control separation
Figure 4.Sankey plot of putative phage contigs and their putative bacterial hosts based on CRISPR spacer sequences in VC_1832_0 and VC_1982_0, which were two of ten differentially abundant VCs between IBS and controls. To produce this plot, phage contigs in the 10 VCs were restricted to those that had a match based on CRISPR spacer sequences to a bacterial contig, resulting in 6 contigs, 4 from viral cluster, VC_1832_0 and 2 from VC_1982_0 (phage contigs beginning with NODE_116 and NODE_932). VC_1832_0 had significantly decreased abundance, and VC_1982_0 had significantly increased abundance in IBS compared with control samples, as reported by DeSeq2. For phage contigs, the putative species is indicated in brackets beside the phage family name